Clinical Trials Logo

Tyrosinemia clinical trials

View clinical trials related to Tyrosinemia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04761588 Active, not recruiting - Tyrosinemia Clinical Trials

Evaluation of TYR Sphere in France

TYR sphere Fra
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

10 participants aged 3 years and over with tyrosinaemia or alkaptonuria will be prescribed Tyr sphere following an assessment of their individual needs by their dietitian. All participants will enter a 4-week evaluation period, assessing adherence and gastrointestinal tolerance. Evaluations of Tyr sphere's palatability are made at the end of the evaluation period. Dried blood spots are taken on days 1 and 28 and once per week in between. Participants who continue to take the product at the end of their evaluation period will enter a follow-up period during which metabolic control, anthropometric and nutritional status data will be collected during the yearly standard of care routine visits.